Showing results (521-530 of 735) with videos related to
Sort By:
Pageof 74
The Lancet. Oncology|February 3, 2020
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trialReinhard Dummer, Jan C Brase, James Garrett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced MelanomaCaroline Robert, Matteo S Carlino, Catriona McNeil, et al.Cancer Discovery|February 20, 2021
A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung CancerHongchen Cai, Su Kit Chew, Chuan Li, et al.Nature Genetics|November 29, 2024
Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTEROlivia Lucas, Sophia Ward, Rija Zaidi, et al.Nature Communications|May 6, 2020
Genomic landscape of platinum resistant and sensitive testicular cancersChey Loveday, Kevin Litchfield, Paula Z Proszek, et al.Nature|March 19, 2026
Thymic health and immunotherapy outcomes in patients with cancerSimon Bernatz, Vasco Prudente, Suraj Pai, et al.Nature Genetics|October 2, 2024
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolutionClare Puttick, Thomas P Jones, Michelle M Leung, et al.Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.Nature Reviews. Cancer|September 16, 2017
Classifying the evolutionary and ecological features of neoplasmsCarlo C Maley, Athena Aktipis, Trevor A Graham, et al.Nature Communications|November 25, 2017
Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doublingInma M Berenjeno, Roberto Piñeiro, Sandra D Castillo, et al.Pageof 74